Stay updated on Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.

Latest updates to the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding notice was added to the page, noting potential delays and directing readers to cc.nih.gov and opm.gov. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check29 days agoChange DetectedAdded a glossary display and new metadata items: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with 'Revision: v3.4.0' in the footer. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check36 days agoChange DetectedSponsor and collaborator information, as well as access to study documents and related metadata, have been removed from the page.SummaryDifference19%

- Check43 days agoChange Detected- Revision: v3.3.4 is now displayed, replacing Revision: v3.3.3. This is a page version update.SummaryDifference0.0%

- Check64 days agoChange DetectedA consolidated Locations section is added listing New South Wales, Victoria, and Western Australia, and the separate NSW, Victoria, and WA location subsections are removed (revision update to v3.3.3).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.